Successful Desensitization to Isatuximab in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis Reply to: Anaphylactic Shock due to Isatuximab and Successful Desensitization

Deze print is 24 uur geldig na het aanmaken. Aangemaakt op: 25-1-2025, 6:07